In cancers such as melanoma, lung cancer, colorectal cancer, and pancreatic cancer, LAG-3 is overexpressed on tumor-infiltrating lymphocytes, contributing to immunosuppression and enabling tumor cells to evade immune attack. Here, LAG3 is linked to neoplasm.